Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.40 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.40 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.40 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.40 |
| ▸ | FFAR2 | O15552 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | USP2 | O75604 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25440185 | 0.83 | MEN1 (0.46) | MEN1KMT2ACHRNB2CHRNB4CHRNA3 | |
| SCHEMBL25439842 | 0.76 | USP2 (0.49) | MEN1KMT2ATDP1CYP3A4SMN1; SMN2 | |
| SCHEMBL20565053 | 0.75 | MEN1 (0.39) | MEN1KMT2ACHRNB2CHRNB4CHRNA3 | |
| SCHEMBL11594986 | 0.74 | MEN1 (0.50) | MEN1KMT2AFFAR2TDP1CYP3A4 | |
| SCHEMBL14422345 | 0.71 | MEN1 (0.47) | MEN1KMT2AFFAR2TDP1CYP3A4 | |
| SCHEMBL20564580 | 0.68 | CHRNB2 (0.39) | MEN1KMT2ACHRNB2CHRNB4CHRNA3 | |
| SCHEMBL5822049 | 0.68 | MEN1 (0.38) | MEN1KMT2ACHRNB2CHRNB4CHRNA3 | |
| SCHEMBL21991450 | 0.68 | CYP1A2 (0.53) | MEN1KMT2ATDP1CYP3A4SMN1; SMN2 | |
| SCHEMBL21103699 | 0.68 | CYP1A2 (0.53) | MEN1KMT2ATDP1CYP3A4SMN1; SMN2 | |
| SCHEMBL25439936 | 0.68 | ALOX5 (0.42) | TDP1NPSR1LMNATSHRACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11767291-B2 | Preparation of secondary amines with electrophilic N-linchpin reagents | WILLIAM MARSH RICE UNIVERSITY (US) | 2023-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11767291-B2 | Preparation of secondary amines with electrophilic N-linchpin reagents | PNMT, NCL, NPM1 | MEN1 296/4885KMT2A 127/4885CHRNB2 1465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.